-

$undefined

N/A

(N/A)

Akebia NASDAQ:AKBA Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts.

Location: 245 1st St, Massachusetts, 02142-1200, US | Website: akebia.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

755.8M

Cash

51.87M

Avg Qtr Burn

-10.16M

Short % of Float

7.76%

Insider Ownership

3.51%

Institutional Own.

28.02%

Qtr Updated

12/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Auryxia (ferric citrate) Details Chronic kidney disease, Anemia, Kidney disease, Hyperphosphatemia	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vafseo™ (Vadadustat) Details Chronic kidney disease, Anemia, Kidney disease	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vafseo™ (Vadadustat) Details Chronic kidney disease, Anemia, Kidney disease	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.